JACKSON ACQUISITION COMPANY

PRO FORMA BALANCE SHEET

Actual as of
December 13,
2021
Pro Forma
Adjustments
As Adjusted
(Unaudited)
(Unaudited)
ASSETS
Current Assets:
Cash
$
1,923,485
$
-
$
1,923,485
Prepaid expenses
26,435
-
26,435
Other current assets
380,000
-
380,000
Total Current Assets
2,329,920
-
2,329,920
Cash held in Trust Account
203,000,000
22,500,000
(a)
225,837,500
787,500
(b)
(450,000
)
(c)
Other assets
374,795
-
374,795
Total Assets
$
205,704,715
$
22,837,500
$
228,542,215
LIABILITIES, COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION AND STOCKHOLDERS' DEFICIT
Current liabilities:
Accounts payable and accrued expenses
$
910,988
$
-
$
910,988
Accrued offering costs
399,000
-
399,000
Overallotment liability
420,760
(345,583
)
(e)
75,177
Total Current Liabilities
1,730,748
(345,583
)

1,385,165
Derivative warrant liabilities
25,819,200
2,524,500
(d)
28,343,700
Deferred underwriting commissions
7,000,000
787,500
(c)
7,787,500
Total Liabilities
34,549,948
2,966,417
37,516,365
COMMITMENTS AND CONTINGENCIES
Class A common stock subject to possible redemption; 20,000,000 and 22,250,000 shares (at $10.15 per share), actual and as adjusted, respectively
203,000,000
22,500,000
(a)
225,837,500
337,500
(h)
Stockholders' Deficit
Preferred stock, $0.0001 par value; 5,000,000 shares authorized; none issued and Outstanding
-
-
-
Class A common stock, $0.0001 par value, 500,000,000 shares authorized, 0 shares issued and outstanding, actual and as adjusted (excluding 20,000,000 and 22,250,000 shares subject to possible redemption, actual and as adjusted, respectively)
-
-
-
Class B common stock, $0.0001 par value, 50,000,000 shares authorized, 5,750,000 and 5,562,500 shares issued and outstanding, actual and as adjusted, respectively
575
(19
)
(g)

556
Additional paid-in capital
-
787,500
(b)
-
(1,237,500
)
(c)
(2,272,500
)
(d)
345,583
(e)
80,552
(f)
19
(g)
(337,500
)
(h)
2,633,846
(i)
Accumulated deficit
(31,845,808
)
(252,000
)
(d)
(34,812,206
)
(80,552
)
(f)
(2,633,846
)
(i)

Total Stockholders' Deficit
(31,845,233
)
(2,966,417
)

(34,811,650
)
Total Liabilities, Common Stock Subject to Possible Redemption and Stockholders' Deficit
$
205,704,715
$
22,837,500
$
228,542,215


JACKSON ACQUISITION COMPANY

Note to Pro Forma Balance Sheet
(unaudited)

NOTE 1 - CLOSING OF OVERALLOTMENT OPTION AND ADDITIONAL PRIVATE PLACEMENT

The accompanying unaudited Pro Forma Balance Sheet presents the Balance Sheet of Jackson Acquisition Company (the "Company") as of December 13, 2021, adjusted for the closing of the partial exercise of the underwriter's overallotment option and related transactions which occurred on January 6, 2022 as described below.

On January 6, 2022, the Company consummated the closing of the sale of 2,250,000 additional units (the "Over-Allotment Units") at a price of $10.00 per Over-Allotment Unit upon receiving notice of the underwriter's election to partially exercise its overallotment option, generating additional gross proceeds of $22,500,000 and incurring additional offering costs of $1,237,500 in underwriting fees. Each Over-Allotment Unit consists of one share of Class A common stock of the Company, par value $0.0001 per share ("Class A Common Stock"), and one-half of one redeemable warrant ("Public Warrant") of the Company. Each whole Public Warrant entitles the holder thereof to purchase one share of Class A Common Stock for $11.50 per share, subject to adjustment.Simultaneously with the closing of the partial exercise of the overallotment option, the Company consummated the private sale of an additional 787,500 warrants (the "OptionPrivate Placement Warrants") to RJ Healthcare SPAC, LLC (the "Sponsor") at a purchase price of $1.00 per OptionPrivate Placement Warrant, generating gross proceeds of $787,500. Of the additional $1,237,500 in underwriting fees, $787,500 is deferred until the completion of the Company's initial business combination. As a result of the underwriter's election to partially exercise its overallotment option, the Sponsor surrendered to the Company for cancellation 187,500 shares of the Company's Class B common stock.

In connection with the closing and sale of the Over-Allotment Units and the Option Private Placement Warrants (together, the "Over-Allotment Closing"), a total of $22,837,500 in proceeds from the Over-Allotment Closing was placed in a U.S.-based trust account maintained by Continental Stock Transfer & Trust Company, acting as trustee.

Pro forma adjustments to reflect the closing of the partial exercise of the underwriter's overallotment option and related transactions are as follows:


Pro forma entry
a.
Cash held in Trust Account
22,500,000
Class A common stock subject to possible redemption
22,500,000
To record sale of 2,250,000 Over-Allotment Units at $10.00 per Over-Allotment Unit.
b.
Cash held in Trust Account
787,500
Additional paid-in capital
787,500
To record sale of 787,500 Option Private Placement Warrants at $1.00 per Option Private Placement Warrant.
c.
Additional paid-in capital
450,000
Cash held in Trust Account
450,000
Additional paid-in capital
787,500
Deferred underwriting compensation
787,500
To record payment of 2% cash underwriting fee and record the liability for 3.5% deferred underwriting compensation on overallotment option.
d.
Accumulated deficit
252,000
Derivative warrant liabilities
252,000
Additional paid-in capital
1,485,000
Derivative warrant liabilities
1,485,000
Additional paid-in capital
787,500
Derivative warrant liabilities
787,500
To record excess proceeds from sale of the Option Private Placement Warrants & adjust fair value of derivative warrants.
e.
Overallotment liability
345,583
Additional paid-in capital
345,583
To adjust overallotment liability.
f.
Accumulated deficit
80,552
Additional paid-in capital
80,552
To record derivative warrant liability costs.
g.
Class B common stock
19
Additional paid-in capital
19
To record forfeiture of 187,500 shares of Class B common stock upon partial exercise of overallotment option.
h.
Additional paid-in capital
337,500
Class A common stock subject to possible redemption
337,500
To adjust Class A common stock subject to redemption to redemption value of $10.15 per share.
i.
Accumulated deficit
2,633,846
Additional paid-in capital
2,633,846
To return additional paid in capital to $0.


Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Jackson Acquisition Co. published this content on 11 January 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 11 January 2022 22:07:05 UTC.